試す 金 - 無料
B&R Acts As A Trusted Automation Partner For Leading Machine Builders
Express Pharma
|November 16-30, 2019
Jhankar Dutta, Managing Director – B&R Industrial Automation talks about how B&R is gearing up for CPHL 2019 and the various progressions the company has made in terms of innovation and digital upgradations
-
Can you explain briefly about the company's portfolio?
B&R Industrial Automation, a member of the ABB group, is an innovative automation company with headquarters in Austria and offices all around the world. As a global leader in industrial automation, B&R combines state-of-the-art technology with advanced engineering to provide customers in virtually every industry with complete solutions for machine and factory automation, motion control, HMI and integrated safety technology. With Industrial IoT communication standards like OPC UA, POWERLINK and openSAFETY as well as the powerful Automation Studio software development environment, B&R is constantly redefining the future of automation engineering. The innovative spirit that keeps B&R at the forefront of industrial automation is driven by a commitment to simplifying processes and exceeding customer expectations.
We are global automation provider with groundbreaking motion control, machine operation and control solutions for pharmaceutical packaging. Our comprehensive portfolio fulfills all the requirements of a pharmaceutical packaging line – regardless of whether the product is in solid, liquid or powder form or whether it is packaged in blisters, paper, plastic, glass or metal. From blister packaging to fillers and cappers, from cartoning to case packers or palletizers, robotics, integrated machine vision and intelligent product transport – we provide the best automation solutions for pharmaceutical packaging machines and plants. We delivers products such as industrial PC, panels, transport systems, vision system, I/O systems, servo and stepper drives and motors, process control systems amongst others. All our hardware and software are fully compliant with FDA 21 CFR Part 11 regulations. In addition, we provide our customers an add-on package of technology libraries that support all FDA criteria for electronic records and signatures.
このストーリーは、Express Pharma の November 16-30, 2019 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Express Pharma からのその他のストーリー
Express Pharma
NEEDLES, PENS AND PRESSURE THE GLP-1 CHALLENGE
As GLP-1 therapies transform diabetes and obesity care, demand for prefilled pens and injectors is soaring. Pharma-device collaborations, analytical innovation, and sustainable design will be key to tackle the growing device bottleneck
7 mins
November 2025
Express Pharma
Unified standards and smarter design are key to unlocking next-generation HVAC performance
Current HVAC design relies on a diverse, and sometimes confusing, array of guidelines issued by regulatory bodies such as WHO, EU GMP, ISO 14644, ISPE Baseline, and ASHRAE/ISHRAE.
2 mins
November 2025
Express Pharma
Kyasanur Forest Disease - How far is a regulatory approved vaccine?
Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral hemorrhagic fever endemic to parts of India, particularly along the Western Ghats and discusses the current status of developing a regulatory-approved KFD vaccine in India
3 mins
November 2025
Express Pharma
India's biopharma industry charts the road from biosimilars to innovation
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies
4 mins
November 2025
Express Pharma
Digital technologies are quietly transforming HVAC into an intelligent compliance partner
Over the last decade, HVAC standards in pharmaceutical manufacturing have undergone a quiet revolution.
2 mins
November 2025
Express Pharma
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand plan to achieve the Rs 250 crore target by FY25-26?Aqualab's journey to Rs 100 crore within three years reflects the strength of a simple yet powerful principle, accessibility through proximity. Our growth has been anchored in three areas: a high-velocity retail network that prioritises last-mile availability, a well-diversified therapeutic portfolio spanning acute and chronic segments, and a strong focus on brand trust built through consistent product quality.
3 mins
November 2025
Express Pharma
Guaranteeing continuity of medicine supply through AI innovation
Hari Kiran Chereddi highlights how AI is transforming pharma supply chains to ensure uninterrupted medicine availability
2 mins
November 2025
Express Pharma
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE
2 mins
November 2025
Express Pharma
Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages
High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments. These doors are engineered to be airtight, creating a reliable barrier between different areas of a facility. Their design ensures durability and minimal maintenance, reducing the frequency of repairs and replacements.
2 mins
November 2025
Express Pharma
Reimagining cold chain: How IoT secures every pharma mile
Swarup Bose, Co-founder and CEO, Celcius Logistics points out that as the demand for temperature-sensitive medicines surges, maintaining an unbroken cold chain has never been more critical. IoT is emerging as the game-changer that ensures every vial and vaccine arrives potent, safe, and on time
3 mins
November 2025
Translate
Change font size

